Menu

Website Search

Calquencehcp.com

calquencehcp.com
Visit calquencehcp.com

  • 6 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

MCL and CLL/SLL Treatment | CALQUENCE® (acalabrutinib) 100 mg capsules | For HCPs

CALQUENCE® (acalabrutinib) is a BTK inhibitor indicated for the treatment of adult patients with R/R Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

Calquencehcp.com thumbnail
Calquencehcp.com thumbnail
99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for calquencehcp.com: 99.86.230.86, 99.86.230.89, 99.86.230.124, 99.86.230.129. Moreover, DNS used with this website include ns-1229.awsdns-25.org, ns-154.awsdns-19.com, ns-1775.awsdns-29.co.uk, ns-979.awsdns-58.net. Subnet identifier ranges from 99.86.0.0 to 99.86.255.255. Classless Inter-Domain Routing (CIDR) is 99.86.0.0/16. ARIN net type is Reallocated.

  • 6 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of calquencehcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2024-04-26. According to open source data, you can reach the owner at domains@astrazeneca.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Sweden.

  • acalabrutinib
  • calquence
  • acalabrutinib dose
  • calquence astrazeneca

Websites similar to calquencehcp.com